Építés alatt – nem éles oldal
Belépés
Befejeződött3. fázis

Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis

A legfontosabb adatok

Ki végzi
Children's Hospital of Philadelphia
Hol
Ann Arbor, Boston, Chicago, Cincinnati, Columbia, Columbus, Dallas, Davis, Denver, Emory, Houston, Los Angeles, Milwaukee, New York, Philadelphia, Pittsburgh, Providence, Richmond, Salt Lake City, San Francisco, Seattle és St Louis (Egyesült Államok)Mind a 22 helyszín megnézése
Azonosító
Állapot
Befejeződött
Fázis
3. fázis
Résztvevők
9041 fő vett részt
Kezdés
2020. aug. 25.
Befejezés
2026. jan. 31.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • Lactated Ringer
  • Normal Saline
  • Plasma-lyte
A regiszteradat frissítve
2026. március 5.

Ki vehet részt

Életkor
2 hónap – 17 év
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 10 feltétel megnézéseKevesebb

Ki vehet részt

  • Males or females age >2 months to <18 years
  • Clinician concern for septic shock, operationalized as:; a "positive" ED sepsis alert confirmed by a physician OR; physician decision to treat for septic shock OR; a physician diagnosis of septic shock requiring parenteral antibiotics and fluid resuscitation
  • Administration of at least one IV/Intraosseous (IO) fluid bolus for resuscitation and additional fluid deemed likely to be necessary to treat poor perfusion, or clinician judgment that >1 fluid bolus is highly likely to be required. Poor perfusion is defined as physician's judgement of hypotension or abnormal (either "flash" or "prolonged") capillary refill
  • Receipt of ≤40 mL/kg IV/IO total crystalloid fluid prior to randomization
  • Parental/guardian permission (informed consent) if time permits; otherwise, Exception from informed consent (EFIC) criteria met

Ki nem vehet részt

  • Indication of declined consent to participate based on presence of an opt-out bracelet with appropriate messaging embossed into the bracelet, the presence of the patient's name on an opt-out list that will be kept up-to-date and checked prior to randomization, or verbal "opt-out" prior to enrollment
  • Known allergy to a crystalloid fluid
  • Treating physician judges that patient's condition deems it unsafe to administer either NS or BF (since patients will be equally likely to receive NS or BF at time of study enrollment), including:; Clinical suspicion for impending brain herniation; Known hyperkalemia, defined as non-hemolyzed whole blood or plasma/serum potassium > 6 mEq/L, based on data available at or before patient meets criteria for study enrollment; Known hypercalcemia, defined as plasma/serum total calcium >12 mg/dL or whole blood ionized calcium >1.35 mmol/L, based on data available at or before patient meets criteria for study enrollment; Known acute fulminant hepatic failure, defined as plasma/serum alanine aminotransferase (ALT) >10,000 U/L or total bilirubin >12.0 mg/dL, based on data available at or before patient meets criteria for study enrollment; Known history of severe hepatic impairment, defined as cirrhosis, "liver failure", or awaiting transplant; Known history of severe renal impairment, defined as peritoneal dialysis or hemodialysis; Known metabolic/mitochondrial disorder, inborn error of metabolism, or primary mineralocorticoid deficiency as reported by participant, legally authorized representative (LAR) or accompanying caregiver, or as listed in the medical record; Other concern for which the treating clinician deems it unsafe to administer either NS or LR
  • Known pregnancy determined by routine history disclosed by patient and/or accompanying acquaintance
  • Known prisoner

Helyszínek itt: Egyesült Államok

  • CS Mott Children's HospitalAnn Arbor, Egyesült Államok
  • Boston Children's HospitalBoston, Egyesült Államok
  • Lurie Children's: Ann & Robert H. Lurie Children's Hospital of ChicagoChicago, Egyesült Államok
  • Cincinnati Children's Hospital Medical CenterCincinnati, Egyesült Államok
  • Children's National Medical CenterColumbia, Egyesült Államok
  • Nationwide Children's HospitalColumbus, Egyesült Államok
  • Dallas Children's: Children's Medical Center Dallas/UT southwesternDallas, Egyesült Államok
  • UC Davis: University of California, DavisDavis, Egyesült Államok
  • Children's Colorado: University of ColoradoDenver, Egyesült Államok
  • Children's Hospital of AtlantaEmory, Egyesült Államok
  • Texas Children's HospitalHouston, Egyesült Államok
  • CHLA: Children's Hospital Los AngelesLos Angeles, Egyesült Államok
  • Milwaukee (MCW): Medical College of WisconsinMilwaukee, Egyesült Államok
  • Columbia: New York-Presbyterian HospitalNew York, Egyesült Államok
  • The Children's Hospital Of PhiladelphiaPhiladelphia, Egyesült Államok
  • Children's Hospital of PittsburghPittsburgh, Egyesült Államok
  • Hasbro Children's HospitalProvidence, Egyesült Államok
  • Children's Hospital of Richmond at VCURichmond, Egyesült Államok
  • Primary Children's/University of UtahSalt Lake City, Egyesült Államok
  • UCSF Benioff Children's HospitalSan Francisco, Egyesült Államok
  • Seattle Children's HospitalSeattle, Egyesült Államok
  • Washington UniversitySt Louis, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

The objectives of this multicenter pragmatic clinical trial are to compare the effectiveness and relative safety of balanced fluid resuscitation versus 0.9% "normal" saline in children with septic shock, including whether balanced fluid resuscitation can reduce progression of kidney injury.

A vizsgálat 2 csoportja

  • Balanced fluids (BF)A vizsgált kezelés

    Balanced fluids (BF), including Lactated Ringer's and Plasma-Lyte (PL), will be administered to patients randomized to the experimental arm. BF will be used for all fluid boluses and maintenance fluids (supplemental electrolytes are allowed) from time immediately after randomization through 11:59 pm of the next calendar day. The determination of when to give fluid, how much fluid to give, how fast to give fluid, and what access to use to administer fluid will remain at the discretion of the treating team.

    Kezelés: Lactated Ringer és Plasma-lyte

  • 0.9% "Normal" Saline Fluid (NS)Már használt kezelés, összehasonlításként

    0.9% "normal" saline (NS) fluid will be administered to patients randomized to the active comparator (control) arm. NS will be used for all fluid boluses and maintenance fluids (supplemental electrolytes are allowed) from time immediately after randomization through 11:59 pm of the next calendar day. The determination of when to give fluid, how much fluid to give, how fast to give fluid, and what access to use to administer fluid will remain at the discretion of the treating team.

    Kezelés: Normal Saline

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Publikációk
A regiszteradat frissítve
2026. március 5.